224 related articles for article (PubMed ID: 21406306)
21. Study on homocysteine levels and methylenetetrahydrofolate reductase gene variant (C677T) in a population of Buenos Aires City.
Fridman O; Porcile R; Vanasco V; Junco MN; Gariglio L; Potenzoni MA; Bañes I; Morales A
Clin Exp Hypertens; 2008 Oct; 30(7):574-84. PubMed ID: 18855261
[TBL] [Abstract][Full Text] [Related]
22. Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population-based case-control study.
Feng LG; Song ZW; Xin F; Hu J
Psychiatry Res; 2009 Aug; 168(3):205-8. PubMed ID: 19564051
[TBL] [Abstract][Full Text] [Related]
23. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
24. Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients.
Kalita J; Srivastava R; Bansal V; Agarwal S; Misra UK
Neurol India; 2006 Sep; 54(3):260-3. PubMed ID: 16936384
[TBL] [Abstract][Full Text] [Related]
25. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
[TBL] [Abstract][Full Text] [Related]
26. Methylenetetrahydrofolate Reductase Gene Polymorphisms (C677T and A1298C) and Hemorrhagic Stroke in Moroccan Patients.
Abidi O; Haissam M; Nahili H; El Azhari A; Hilmani S; Barakat A
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1837-1843. PubMed ID: 29555401
[TBL] [Abstract][Full Text] [Related]
27. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
28. Methylenehydrofolate reductase (C677T) polymorphism and large artery ischemic stroke subtypes.
They-They TP; Nadifi S; Rafai MA; Battas O; Slassi I
Acta Neurol Scand; 2011 Feb; 123(2):105-10. PubMed ID: 20637011
[TBL] [Abstract][Full Text] [Related]
29. Methylenetetrahydrofolate reductase gene polymorphism and childhood stroke.
Morita DC; Donaldson A; Butterfield RJ; Benedict SL; Bale JF
Pediatr Neurol; 2009 Oct; 41(4):247-9. PubMed ID: 19748043
[TBL] [Abstract][Full Text] [Related]
30. Genetic risk factors for arterial ischemic stroke in children: a possible MTHFR and eNOS gene-gene interplay?
Djordjevic V; Stankovic M; Brankovic-Sreckovic V; Rakicevic L; Radojkovic D
J Child Neurol; 2009 Jul; 24(7):823-7. PubMed ID: 19372095
[TBL] [Abstract][Full Text] [Related]
31. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
[TBL] [Abstract][Full Text] [Related]
32. Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia.
García-Miss Mdel R; Pérez-Mutul J; López-Canul B; Solís-Rodríguez F; Puga-Machado L; Oxté-Cabrera A; Gurubel-Maldonado J; Arankowsky-Sandoval G
J Psychiatr Res; 2010 May; 44(7):441-6. PubMed ID: 19939410
[TBL] [Abstract][Full Text] [Related]
33. Case-control Study of methylenetetrahydrofolate reductase mutations and hyperhomocysteinemia and risk of stroke.
Almawi WY; Khan A; Al-Othman SS; Bakhiet M
J Stroke Cerebrovasc Dis; 2009; 18(5):407-8. PubMed ID: 19717029
[TBL] [Abstract][Full Text] [Related]
34. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
[TBL] [Abstract][Full Text] [Related]
35. Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population.
Sameer AS; Shah ZA; Nissar S; Mudassar S; Siddiqi MA
Genet Mol Res; 2011 Jun; 10(2):1200-10. PubMed ID: 21732284
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of thrombophilic mutations and ACE I/D polymorphism in Turkish ischemic stroke patients.
Celiker G; Can U; Verdi H; Yazici AC; Ozbek N; Atac FB
Clin Appl Thromb Hemost; 2009; 15(4):415-20. PubMed ID: 18387982
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of methylenetetrahydrofolate reductase C677T and risk of ischemic stroke in a southern Chinese Hakka population.
Hou J; Zeng X; Xie Y; Wu H; Zhao P
Medicine (Baltimore); 2018 Dec; 97(51):e13645. PubMed ID: 30572478
[TBL] [Abstract][Full Text] [Related]
38. Hyperhomocysteinaemia in a young woman presenting with stroke, associated with methylene tetrahydrofolate reductase C677T homozygosity.
Saldana Chaparro R; Barron JL
Ann Clin Biochem; 2004 May; 41(Pt 3):241-4. PubMed ID: 15117441
[TBL] [Abstract][Full Text] [Related]
39. Significant impact of MTHFR C677T polymorphism on plasma homovanillic acid (HVA) levels among alcohol-dependent patients.
Lutz UC; Batra A; Wiatr G; Machicao F; Kolb W; Maurer S; Buchkremer G; Köhnke MD
Addict Biol; 2007 Mar; 12(1):100-5. PubMed ID: 17407503
[TBL] [Abstract][Full Text] [Related]
40. C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas.
Kafadar AM; Yilmaz H; Kafadar D; Ergen A; Zeybek U; Bozkurt N; Kuday C; Isbir T
Anticancer Res; 2006; 26(3B):2445-9. PubMed ID: 16821630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
